Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance at Dec. 31, 2023	$ 1,827	$ 100,841,416	$ (1,817,640)	$ (96,499,518)	$ (569,749)	$ 1,956,336
Beginning balance, shares at Dec. 31, 2023	182,625
Stock based compensation		351,488				351,488
Foreign exchange translation gain					17,906	17,906
Net loss				(2,456,915)		(2,456,915)
Common stock sold under the Equity Distribution Agreement, net of offering costs of $583,713	$ 1,112	1,807,677				1,808,789
Common stock sold under the Equity Distribution Agreement, net of offering cost, shares	111,200
Issuance of direct offering shares	$ 152	322,301				322,453
Issuance of direct offering shares, shares	15,246
Exercise of Inducement Warrants for common stock	$ 1,303	2,675,677				2,676,980
Exercise of Inducement Warrants for common stock, shares	130,267
Proceeds from the subscription receivable related to the issuance of Inducement Warrants, net of offering costs of $12,821		(12,821)	280,500			267,679
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance	$ 469	(469)	1,537,140			1,537,140
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance, shares	46,934
Balance at Mar. 31, 2024	$ 4,863	105,985,269		(98,956,433)	(551,843)	6,481,856
Ending balance, shares at Mar. 31, 2024	486,272
Balance at Dec. 31, 2024	$ 6,780	108,255,049		(106,074,505)	(594,517)	1,592,807
Beginning balance, shares at Dec. 31, 2024	678,002
Issuance of common stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487	$ 12,293	4,232,174				4,244,467
Issuance of common stock and Series A and B and prefunded warrants for cash, net of offering costs, shares	1,229,330
Issuance of common shares for vested RSAs	$ 146	(146)
Issuance of common shares for vested RSU, shares	14,586
Issuance of common shares for exercise of warrants	$ 4,623	70,421				75,044
Issuance of common shares for exercise of warrants, shares	462,336
Issuance of round up shares	$ 874	(874)
Issuance of round up shares, shares	87,402
Stock based compensation		193,848				193,848
Foreign exchange translation gain					(3,487)	(3,487)
Net loss				(2,184,966)		(2,184,966)
Balance at Mar. 31, 2025	$ 24,716	$ 112,750,472		$ (108,259,471)	$ (598,004)	$ 3,917,713
Ending balance, shares at Mar. 31, 2025	2,471,656